Co
Not verified

Contineum Therapeutics, Inc.

What we write about

BiotechnologyHealthMedicine - variousPharmaceuticalsWEB AND SOCIAL NETWORK
12/12/2025
Finance
Biotechnology
Health
Pharmaceuticals
Medicine - various
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
1.00
11/12/2025
Finance
Biotechnology
Psychiatry
Health
Pharmaceuticals
Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
1.00
30/10/2025
Biotechnology
Health
Pharmaceuticals
Medicine - various
stock market
Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
1.00
28/08/2025
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Eventi
WEB AND SOCIAL NETWORK
Contineum Therapeutics to Present at September Investor Conferences
1.00
05/08/2025
Biotechnology
Health
Pharmaceuticals
Medicine - various
stock market
Contineum Therapeutics Reports Second-Quarter 2025 Financial Results; Updates Key Clinical Development Milestones
1.00
25/06/2025
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Industria
Contineum Therapeutics Provides Update on Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
1.00
15/05/2025
Eventi
WEB AND SOCIAL NETWORK
Biotechnology
Pharmaceuticals
Health
Medicine - various
Contineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare Conference
1.00
14/05/2025
stock market
Biotechnology
Health
Pharmaceuticals
Medicine - various
Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
1.00

Contact details

Social Media

Followers
0
Compatibility
0